In addition, long~term (L e. chronic) iron overload can result from the transfusion therapy of Cooley's anemia (S~thalassemia major). 7 a blood disorder affecting approximately three million people worldwide, and is the major cause of death associated with this disease.
The present treatment for transfusional iron overload in the S~ thalassemic is either subcutaneous or intravenous slow infusion of Desferal®, the mesylate salt of desferrioxamine B. This therapy has exhibited efficacies as low as 10%, presumably due to the instability
o-the rug in t e o y an 1ts rap1 excret1.on. Then aq. HCl (6 ~. 50 mL) was added (Caution, H 2 t) dropwise and maintained at reflux for 60 hr. Evaporation in vacuo, followed by coevaporation with methanol to volatilize the borates gave crude, dry solid which, when crystallized from boiling methanol by the addition of ethanol (cooling and scratching), gave hygroscopic 3 (9.9 g, 70%, dried in vacuo at 70°,
"'
~ --- of water (50 mL) followed by aq. NaOH (L~O mL, 6 M) gave a _(pH "' 6) mixture which was filtered and the cake washed well with water. (10) .
'\1\i
In an argon atmosphere, 9 (5.0 g. 6. ·7 mmol) 7.6 (see Table II ). The break at a= 3 is consistent with these results.
These protons are much more acidic than those of enterobactin and previously synthesized unsulfonated catechoylamide sequestering agents.
The potentiometric titration of the ferric complex (curve b in Figure 3 ) shows that initial complexation is quite strong, as is typical for iron(III) catecholate complexes. There is a three-proton buffer region between pH 5.5 and 7.
3. Least~squares refinement of these data the protonation constants listed in Table II for the tris complex is 487 nm (E = 5390 J'C 1 em max Upon protonation. the peak shifts to lower energy with a maximum near 512 nm. The proton-dependent formation constant (K*, Table II where n = 4-6. respectively). Although NAcMECM1S is sulfonated, n the log K~~~ for this ligand is comparable to that of enterobactin.
Since the carbonyl group is no longer conjugated to the catechol ring, its electron withdrawing capacity has been replaced by a slightly electron donating methylene group. In essence, the increased electron withdrawing ability of the sulfonyl group is canceled by the loss of the alpha carbonyl and is reflected in the ligand protonation constants.
In general, however, sulfonated ligands, as discussed below. become more effective chelating agents at physiological pH. The metal chelate protonation equilibria for Me 3 MECAMS are similar to those of enterobactin, MECAM, and MECAMS. Upon protonation, a shift from a catecholate to a salicylate mode of bonding (via the amide carbonyl and ortho phenolate oxygens) has been proposed for these three 13 
ligands.
The visible spectra and proton stoichometry determined from 6-a Schwarzenbach plot for Fe(Me 3 MECAMS) are consistent with those of the previously studied ligands, and would suggest that this complex also undergoes a shift to salicylate coordination.
In contrast to ligands with a carbonyl group alpha to the catechol ring, the low pH mode of bonding in NAcMECAMS is via bis~catecholate coordination. This arrangement of iron binding groups is preferable to a salicylate bonding mod;-: for two reasons. First, the carbonyl oxygen has less anionic character when it is not conjugated to the catecholate ring. This decrease in charge on the oxygen lowers its affinity for the hard Fe 3 + ion. Second, the formation of a complex via the .2_-phenol and carbonyl oxygens would require an eight-membered chelate ring, whereas salicylate coordination is achieved by a stable five-membered ring. The results indicated that both natural and synthetic catechoylamides were capable of kinetically affecting exchange of transferrin-bound iron. The rate constant reported for Me 3 MECAMS (Table IV) bN,N~bis(2-hydroxybenzyl)-ethylenediamine-N,N 1 -diacetic acid.
cEthylene-1,2-bis(2~hydroxyphenylglycine).
dDiethylenetriaminepentaacetic acid.
eEthylenediaminediacetic acid.
fl,2-Dihydroxy-3,5-disulfobenzene. 
